Skip to main content
. 2022 Mar 3;36(2):821–832. doi: 10.21873/invivo.12769

Table III. (Significant) Influencing factors that led to a change from cisplatin to carboplatin/paclitaxel evaluated in univariate and multivariate logistic regression.

graphic file with name in_vivo-36-826-i0001.jpg

UICC: Union Internationale Contre le Cancer; RCT: radiochemotherapy; ACCI: Age-Adjusted Charlson Comorbidity Index. Bold p-Values indicate statistical significance.